Furthermore, FABP4 promoted synovitis, angiogenesis, and cartilage degeneration to exacerbate the severity of RA, while BMS309403 and anagliptin effectively inhibited the pathological effects of FABP4 on RA progression. The gene discussed is FABP4; the disease is rheumatoid arthritis.